Literature DB >> 72045

Detection of Epstein-Barr virus antigens with enzyme-conjugated antibody.

D J Granlund, A P Andrese.   

Abstract

Monospecific conjugated (fluorescein isothiocynate and horseradish peroxidase) goat antisera, prepared against three human immunoglobulin classes, IM (mu), IgG (gamma) and IgA (alpha), were compared for their ability to detect human Ig classes possessing specificity for Epstein-Barr virus (EBV) viral capsid antigens (VCA) in a chronically infected human lymphoid cell line, P3J-HRIK. It was determined that the enzyme system was significantly more sensitive than immunofluorescence in detecting most of the immunoglobulins in sera from cancer patients. Some patients with nasopharyngeal carcinomas (NPC) had extremely high levels of EBV-specific IgA, whereas cancers other than NPC may have lower EBV-specific IgA titers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72045     DOI: 10.1002/ijc.2910200404

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Enzyme immunoassay for detection of antibody to Epstein-Barr virus-specific early antigen.

Authors:  D J Garnlund; P H Levine; D A Fuccillo
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

2.  Infection of rhesus monkeys and chimpanzees with Epstein-Barr virus.

Authors:  P H Levine; S A Leiseca; J F Hewetson; K A Traul; A P Andrese; D J Granlund; P Fabrizio; D A Stevens
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.

Authors:  K Goldstein; P K Lai; M Lightfoote; A P Andrese; D Fuccillo; R J Connor; P H Levine
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

4.  A human tumour-associated membrane antigen from squamous-cell carcinoma of the lung.

Authors:  R W Veltri; P E Maxim; J M Boehlecke
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.